Thomas C. Boone

Health Technology

Consumer Services

Profile

Thomas C.
Boone worked as a Senior Vice President of Protein Sciences at Oxford BioTherapeutics Ltd., Vice President of Protein Sciences at Amgen, Inc., and Vice President of Preclinical Research & Development at Zymeworks BC, Inc. He obtained undergraduate degrees from the University of California, Los Angeles and the University of California, Davis.

Former positions of Thomas C. Boone

Companies	Position	End
AMGEN INC.	Corporate Officer/Principal	-
Zymeworks BC, Inc. Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada.	Chief Tech/Sci/R&D Officer	-
Oxford BioTherapeutics Ltd. Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom.	Corporate Officer/Principal	-

See the detail of Thomas C. Boone's experience

Training of Thomas C. Boone

University of California, Davis	Undergraduate Degree
University of California, Los Angeles	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies